Proteomic analysis of cerebrospinal fluid changes related to postmortem interval.

@article{Finehout2006ProteomicAO,
  title={Proteomic analysis of cerebrospinal fluid changes related to postmortem interval.},
  author={Erin J. Finehout and Zsofia Franck and Norman Relkin and Kelvin H. Lee},
  journal={Clinical chemistry},
  year={2006},
  volume={52 10},
  pages={
          1906-13
        }
}
BACKGROUND The study of proteins with altered production in postmortem cerebrospinal fluid (CSF) compared with antemortem CSF may improve the understanding of biochemical changes that occur immediately after death. METHODS Two CSF samples (1 antemortem and 1 postmortem) were collected from 7 patients and analyzed by 2-dimensional gel electrophoresis. An analysis was also performed to identify proteins that showed a correlation between concentration change and postmortem interval. Tandem mass… 
View on PubMed
clinchem.aaccjnls.org
33 Citations
Highly Influential Citations
2
Background Citations
10
Methods Citations
1
Results Citations
3

33 Citations

Citation Type

Citation Type

Talin: A potential protein biomarker in postmortem investigations.
Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.
Proteomic Analysis of Brain and Cerebrospinal Fluid from the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Potential Biomarkers.
TLDR
This study analyzes autopsy brain and matching CSF samples from controls and three genetically distinct NCLs to identify candidate biomarkers, finding that changes in protein expression compared with control were most similar between CLN2 disease and CLN3 disease.
Analysis of Cerebrospinal Fluid Proteins Reveals Asso- ciation of Calbindin 1 Concentrations with Neurological Outcomes in Patients Resuscitated from Out-of-Hospital Cardiac Arrest: A Proteomics-Based Pilot Study
TLDR
A combination of liquid chromatography-tandem mass spectrometry and western blotting is useful to analyze CSF from critical care unit patients, including brain-specific proteins, such as enolase 2 and calbindin 1.
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers
TLDR
The cerebrospinal fluid (CSF) circulates within the CNS where it plays an essential physiological role in homeostasis of neuronal cells and gives a unique opportunity to detect and describe biomarkers in neurological affections.
Serial analyses of postmortem changes in human skeletal muscle: A case study of alterations in proteome profile, histology, electrolyte contents, water composition, and enzyme activity
TLDR
These findings demonstrate that storing the samples at 4°C could delay some of the aforementioned changes, which occurred more rapidly at 25°C, and suggest that muscle proteome profile, histology, electrolyte contents, water composition, and enzyme activity should be analyzed within the optimal postmortem intervals, which vary among individual analyses, to obtain the most reliable data.
Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects
TLDR
Differences in the CSF proteome from post mortem and living ALS subjects using a mass spectrometric approach highlight the importance of utilizing CSF from living ALSSubjects near the time of symptom onset for the identification of early protein biomarkers, although some protein alterations that occur early in the disease process are maintained throughout the course of disease and in post mortems.
Biochemical markers of time since death in cerebrospinal fluid: A first step towards “Forensomics”
TLDR
This literature review focuses on the panel of biomarkers that have been studied in CSF based on their potential of offering information on the time of death, and the interest in these biomarkers for casework and the research perspectives in this field are discussed.
Proteomics of human cerebrospinal fluid – the good, the bad, and the ugly
  • Jing Zhang
  • Biology
    Proteomics. Clinical applications
  • 2007
TLDR
The current status of characterization of the human CSF proteome and biomarker discovery for major neurodegenerative disorders, i.e., Alzheimer's disease and Parkinson's disease, is summarized and a few essential caveats involved in several steps of CSf proteomics are addressed.
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
TLDR
Combining biomarker data from multiple laboratories may create a consensus panel of proteins that may serve as a diagnostic tool for this neurodegenerative disorder.
...
1
2
3
4
...

References

SHOWING 1-10 OF 36 REFERENCES
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease.
Proteome study of human cerebrospinal fluid following traumatic brain injury indicates fibrin(ogen) degradation products as trauma-associated markers.
TLDR
Proteomic analysis including two-dimensional gel electrophoresis combined with mass spectrometry analysis was used to compare the CSF protein profile of severe TBI patients and controls, finding proteins belonging to the acute phase response showed an increased expression in severeTBI patients.
Identification of post‐mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration
TLDR
Post‐mortem cerebrospinal fluid samples were used as a model of massive brain insult to identify new markers potentially relevant for neurodegeneration, indicating that the identified proteins indeed represent potential biomarkers of brain damage.
Critical evaluation of postmortem changes in human autopsy cisternal fluid. Enzymes, electrolytes, acid-base balance, glucose and glycolysis, free amino acids and ammonia. Correlation to total brain ischemia.
By studying early postmortem changes in cerebrospinal fluid (CSF) it is possible to draw conclusions as to premortem focal brain cell injury and terminal brain ischemia. Cisternal fluid (CF) from 40…
Towards two‐dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual
TLDR
Test the ability of state‐of‐the‐art two‐dimensional electrophoresis (2‐DE) technology to enable the proteome mapping of ante mortem cerebrospinal fluid (CSF) from a single individual and creates a highly detailed 2‐DE map of the CSF proteome.
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
TLDR
The presence in the CSF of novel potential biomarkers for AD is demonstrated, which may be used for the diagnosis and perhaps the assessment of the severity and progression of the disease.
Dynamics of brain-derived proteins in cerebrospinal fluid.
  • H. Reiber
  • Biology, Medicine
    Clinica chimica acta; international journal of clinical chemistry
  • 2001
PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke.
TLDR
The utility of analysis of postmortem CSF proteins as a first step in the discovery of plasma markers of ischemic brain injury is demonstrated, and PARK7 and NDKA may be useful plasma biomarker of stroke.
Enzyme level changes in the cerebrospinal fluid of patients with acute stroke.
TLDR
It is suggested that CSF enzyme determinations may provide supplementary information as to the extent and severity of brain damage and the recovery potentials of selected patient groups with strokes.
Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid Separate areas of reference
...
1
2
3
4
...